WilliamHikaruMatsuiMD

PubMed

• 4 citations
  SLC25A51 decouples the mitochondrial NAD/NADH ratio to control proliferation of AML cells.
  Mu-Jie Lu, Jonathan Busquets, Valeria Impedovo, Crystal N Wilson, Hsin-Ru Chan
  Cell Metabolism. 2024-04-02
• 2 citations
  Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
  Sarah Aminov, Orsi Giricz, David T Melnekoff, R Alejandro Sica, Veronika Polishchuk
  The Journal of Clinical Investigation. 2024-02-20
• 2 citations
  CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.
  Michael J VanWyngarden, Zachary J Walker, Yang Su, Olivia Perez de Acha, Brett M Stevens
  Cancers. 2023-11-09

Journal Articles

• Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-vers...  
  Kanakry JA, Kasamon YL, Bolanos-Meade J, Borrello IM, Brodsky RA, Fuchs EJ, Ghosh N, Gladstone DE, Gocke CD, Huff CA, Kanakry CG, Luznik L, Matsui W, Mogri HJ, Swinnen..., Biology Blood and Marrow Transplantation, 7/18/2013
• Cancer stem cells in lung cancer: Evidence and controversies  
  Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN, Respirology, 7/1/2013
• Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation  
  Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir A, Gustin JP, Rosen DM, Denmeade S, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, Croessm..., Cancer Reserarch, 1/1/2013
• Cancer stem cells: relevance to clinical transplantation  
  Ghiaur G, Gerber JM, Matsui W, Jones RJ, Current Opinion in Oncology, 1/1/2012
• Brief Intensive Therapy for Older Adults with Newly Diagnosed Burkitt or Atypical Burkitt Lymphoma/Leukemia  
  Kasamon YL, Brodsky RA, Borowitz MJ, Ambinder RF, Crilley PA, Cho SY, Tsai HL, Douglas Smith B, Gladstone DE, Carraway HE, Huff CA, Matsui WH, Bolanos-Meade J, Jones R..., Leukemia Lymphoma, 1/1/2012
• The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models  
  Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, Rajeshkumar NV, Molecular Cancer Therapeutics, 1/1/2012
• Bruton's tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma  
  Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elia..., Blood, 1/1/2012
• Heterogeneity and targeting of pancreatic cancer stem cells  
  Penchev VR, Rasheed ZA, Maitra A, Matsui W, Clinical Cancer Research, 1/1/2012
• Molecular pathways: the Hedgehog signaling pathway in cancer  
  McMillan R and Matsui W, Clinical Cancer Research, 1/1/2012
• Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells  
  Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, Yarmus..., Cancer Cell, 1/1/2012
• Hedgehog pathway as a drug target: Smoothened inhibitors in development  
  Lin TL, Matsui W, OncoTargets Therapy, 1/1/2012
• A DNA hypermethylation module for the stem/progenitor cell signature of cancer  
  Easwaran H, Johnstone S, Vanneste L, Ohm J, Mosbruger T, Wang Q, Aryee MJ, Joyce P, Ahuja N, Weisenberger D, Collisson E, Zhu JC, Yegnasubramanian S, Matsui W, Baylin SB, Genome Research, 1/1/2012
• A phase II study of rituximab-ABVD in classical Hodgkin lymphoma  
  Kasamon YL, Jacene HA, Gocke CD, Swinnen LJ, Gladstone DE, Perkins B, Link BK, Popplewell LL, Habermann TM, Herman JM, Matsui WH, Jones RJ, Ambinder RF, Blood, 1/1/2012
• Chloroquine improves survival and hematopoietic recovery following lethal low dose-rate radiation  
  Lim Y, Hedayati M, Merchant AA, Zhang Y, Yu H, Kastan M, Matsui W, DeWeese T, Interna J Rad Oncol, Biol, Physics, 1/1/2012
• Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model  
  Van Valckenborgh E, Matsui W, Agarwal P, Lub S, Dehui X, De Bruyne E, Menu E, Empsen C, van Grunsven L, Agarwal J, Wang Q, Jernberg-Wiklund H, Vanderkerken K, Leukemia, 1/1/2012
• Biological and clinical relevance of stem cells in pancreatic adenocarcinoa  
  Rasheed ZA, Matsui W, J Gastroenterology Hepatology, 1/1/2012
• Relationships between folate and inflammatory features of asthma  
  Lin JH, Matsui W, Aloe C, Peng RD, Diette GB, Breysse PN, Matsui EC, Journal of Allergy and Clinical Immunology, 1/1/2012
• Autologous stem cell transplantation and multiple myeloma cancer stem cells  
  Matsui W, Borrello I, Mitsiades C, Biol Blood Marrow Transplantation, 1/1/2011
• Development and maintenance of cancer stem cells under chronic inflammation  
  Tanno T, Matsui W, J Nippon Med School, 1/1/2011
• The redox-sensitive transcription factor, Nrf2, regulates murine hematopoietic stem cell survival independent of ROS levels  
  Merchant A, Singh A, Matsui W, Biswal, S, Blood, 1/1/2011
• Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models  
  Feldmann G, Mishra A, Bisht S, Karikari C, Garrido-Laguna I, Rasheed Z, Ottenhof N, Dadon T, Alvarez H, Fendrich V, Rajeshkumar NV, Matsui W, Brossart P, Hidalgo M, Ba..., Ca Biol Therapy, 1/1/2011
• High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas  
  Gladstone DE, Bolanos-Meade J, Huff CA, Zahurak M, Flinn I, Borrello I, Luznik L, Fuchs E, Kasamon Y, Matsui W, Powell J, Levitsky H, Brodsky RA, Ambinder R, Jones RJ,..., Leukemia Lymphoma, 1/1/2011
• Emerging concepts in clinical targeting of cancer stem cells  
  Rasheed ZA, Kowalski J, Smith BD, Matsui W, Stem Cells, 1/1/2011
• Characterization of chronic myeloid leukemia stem cells  
  Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ, Am J Hematology, 1/1/2011
• Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF  
  Smith BD, Jones RJ, Cho E, Kowalski J, Karp JE, Gore SD, Vala M, Meade B, Baker SD, Zhao M, Piantadosi S, Zhang Z, Blumenthal G, Warlick ED, Brodsky RA, Murgo A, Rudek..., Leukemia Research, 1/1/2011
• Join now to see all